Evidence map›Paper›PMID 39211664›Full record

ArticleCureus2024

Pediatric Respiratory Infections ‎After the COVID-19 Pandemic: A Single-Center Experience.

Walaa A Shahin, Khaled Alamri, Eshraq Omar, Yousef Elmahmoud, Hayam H Ahmed, Faisal Al Enezi, Ghada Alshaman, Abdulrahman Alodayani, Hassan Alahmari

Abstract read
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Walaa A ShahinPediatric Pulmonology, Cairo University Pediatric Hospital, Cairo, EGY.
Khaled AlamriAdvanced General Pediatrics, Prince Sultan Military Medical City, Riyadh, SAU.
Eshraq OmarAdvanced General Pediatrics, Prince Sultan Military Medical City, Riyadh, SAU.
Yousef ElmahmoudAdvanced General Pediatrics, Prince Sultan Military Medical City, Riyadh, SAU.
Hayam H AhmedAdvanced General Pediatrics, Prince Sultan Military Medical City, Riyadh, SAU.
Faisal Al EneziAdvanced General Pediatrics, Prince Sultan Military Medical City, Riyadh, SAU.
Ghada AlshamanAdvanced General Pediatrics, Prince Sultan Military Medical City, Riyadh, SAU.
Abdulrahman AlodayaniPediatric Infectious Diseases, Prince Sultan Military Medical City, Riyadh, SAU.
Hassan AlahmariAdvanced General Pediatrics, Prince Sultan Military Medical City, Riyadh, SAU.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Pediatric respiratory infections, mainly bronchiolitis, are a substantial clinical burden. The most common etiology is respiratory syncytial virus (RSV). Other viruses include human rhinovirus, human metapneumovirus, influenza, adenovirus, coronavirus, and parainfluenza viruses. Objective We aimed to study the epidemiology and clinical characteristics of children with confirmed viral bronchiolitis and flu after the COVID-19 pandemic season and compare the behavior of each virus. Methods This retrospective observation study was done over seven months, from October 2022 to April 2023. All children (0-14) were included in the study if they met the clinical diagnosis of bronchiolitis or flu. Viral etiology is confirmed by PCR, using the respiratory panel available in our center which included the detection of four viruses: COVID-19, RSV, influenza A, and B. Clinical data, lab results, and X-rays were collected and correlated with each viral infection for all admitted patients. Results We recruited 237 children with bronchiolitis and flu symptoms from October 2022 to April 2023. The peak of infections (41%) was in November. Seasonal variations for each virus showed distinct patterns across the year. RSV peaked at the beginning of the season, gradually declining after that. In contrast, influenza A and B maintained a relatively consistent presence throughout the season. Meanwhile, COVID-19 reached its peak during March and April. One hundred forty-four (60%) of the patients were under two years of age. RSV was predominant in 150 patients (63.3%). COVID-19 was only detected in 25 patients (10%), whereas influenza A and B were equally isolated in 31 (13%) patients each. Fifty-one children (21%) were initially sick and required pediatric intensive care unit (PICU) admission, with no deaths reported. Notably, COVID-19 had a milder disease course, a shorter length of stay (LOS) in the hospital (two days) and a shorter duration of illness (five days) compared to other viruses. RSV infection was linked to more profound hypoxia and more sick children with more extended hospital stays. Conclusion Our study showed that, following the pandemic and the release of lockdown measures, there was another peak of upper respiratory tract infections (URTI) and flu, which was more aggressive, primarily due to other viruses, especially RSV. This resurgence was associated with more severe respiratory symptoms and an increased need for hospitalization. Notably, children with COVID-19 were in better condition compared to those with RSV.

Indexed as

bronchiolitiscovid-19fluinfantsinfluenzakingdom of saudi arabia (ksa)lower respiratory tract infectionpediatric infectionsrespiratory distressrsv

Identifiers

PMID39211664
PMCPMC11361736

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.